These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 30529127

  • 21. Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study.
    Scarpino S, Leone A, Galafate D, Pepe F, Malapelle U, Villani S, Giarnieri E, Maurizi G, De Vitis C, Mancini R, Mancini M, Di Napoli A, Vecchione A, Pilozzi E.
    Int J Mol Sci; 2024 Jul 11; 25(14):. PubMed ID: 39062837
    [Abstract] [Full Text] [Related]

  • 22. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S, Dai L, Wang L, Wang W, Wu D, Wang K, He Z, Wang A, Chen H, Zhang P, Dong X, Dong YA, Wang K, Yao M, Wang M.
    Oncologist; 2019 Nov 11; 24(11):e1070-e1081. PubMed ID: 30902917
    [Abstract] [Full Text] [Related]

  • 23. Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
    Garinet S, Lupo A, Denize T, Loyaux R, Timsit S, Gazeau B, Fabre E, Maaradji Z, Gibault L, Giroux-Leprieur E, Duchemann B, Monnet I, Jouveshomme S, Aldea M, Besse B, Le Pimpec-Barthes F, Leroy K, Wislez M, Blons H.
    Pathology; 2024 Aug 11; 56(5):702-709. PubMed ID: 38834439
    [Abstract] [Full Text] [Related]

  • 24. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
    Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB.
    J Thorac Oncol; 2018 Dec 11; 13(12):1873-1883. PubMed ID: 30195702
    [Abstract] [Full Text] [Related]

  • 25. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
    Velizheva NP, Rechsteiner MP, Valtcheva N, Freiberger SN, Wong CE, Vrugt B, Zhong Q, Wagner U, Moch H, Hillinger S, Schmitt-Opitz I, Soltermann A, Wild PJ, Tischler V.
    Pathol Res Pract; 2018 Apr 11; 214(4):572-578. PubMed ID: 29580750
    [Abstract] [Full Text] [Related]

  • 26. Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma.
    Brisudova A, Skarda J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun 11; 164(2):127-132. PubMed ID: 32284620
    [Abstract] [Full Text] [Related]

  • 27. Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified Reaction.
    Song Z, Xu C, He Y, Li F, Wang W, Zhu Y, Gao Y, Ji M, Chen M, Lai J, Cheng W, Benes CH, Chen L.
    Clin Chem; 2020 Jan 01; 66(1):178-187. PubMed ID: 31810998
    [Abstract] [Full Text] [Related]

  • 28. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC, Lai GGY, Tan GS, Poon SY, Doble B, Lim TH, Aung ZW, Takano A, Tan WL, Ang MK, Tan BS, Devanand A, Too CW, Gogna A, Ong BH, Koh TPT, Kanesvaran R, Ng QS, Jain A, Rajasekaran T, Lim AST, Lim WT, Toh CK, Tan EH, Lim TKH, Tan DSW.
    Lung Cancer; 2020 Jan 01; 139():207-215. PubMed ID: 31835042
    [Abstract] [Full Text] [Related]

  • 29. Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
    Wang B, Chen R, Wang C, Guo J, Yuan M, Chen H, Xia X, Zhong D.
    Hum Pathol; 2021 Aug 01; 114():90-98. PubMed ID: 34019866
    [Abstract] [Full Text] [Related]

  • 30. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 31. The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer.
    Szpechcinski A, Moes-Sosnowska J, Skronska P, Lechowicz U, Pelc M, Szolkowska M, Rudzinski P, Wojda E, Maszkowska-Kopij K, Langfort R, Orlowski T, Sliwinski P, Polaczek M, Chorostowska-Wynimko J.
    Int J Mol Sci; 2024 Jul 19; 25(14):. PubMed ID: 39063150
    [Abstract] [Full Text] [Related]

  • 32. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA, Frohnauer J, Merkelbach-Bruse S, Schildhaus HU, Dimmler A, Schubert T, Boltze C, König H, Fuchs F, Sirbu H, Rieker RJ, Agaimy A, Hartmann A, Haller F.
    Lung Cancer; 2014 Jun 19; 84(3):215-21. PubMed ID: 24674157
    [Abstract] [Full Text] [Related]

  • 33. Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach.
    Sui JSY, Finn SP, Gray SG.
    Methods Mol Biol; 2021 Jun 19; 2279():145-155. PubMed ID: 33683691
    [Abstract] [Full Text] [Related]

  • 34. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
    Moore DA, Balbi K, Ingham A, Arkenau HT, Bennett P.
    J Clin Pathol; 2018 Nov 19; 71(11):1001-1006. PubMed ID: 30054375
    [Abstract] [Full Text] [Related]

  • 35. Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practice.
    Rao W, Guo L, Ling Y, Dong L, Li W, Ying J, Li W.
    J Cancer Res Clin Oncol; 2023 Jul 19; 149(8):4889-4897. PubMed ID: 36305947
    [Abstract] [Full Text] [Related]

  • 36. Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Kim EK, Kim KA, Lee CY, Kim S, Chang S, Cho BC, Shim HS.
    Clin Lung Cancer; 2019 Jan 19; 20(1):e123-e132. PubMed ID: 30391211
    [Abstract] [Full Text] [Related]

  • 37. Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
    Lindquist KE, Karlsson A, Levéen P, Brunnström H, Reuterswärd C, Holm K, Jönsson M, Annersten K, Rosengren F, Jirström K, Kosieradzki J, Ek L, Borg Å, Planck M, Jönsson G, Staaf J.
    Oncotarget; 2017 May 23; 8(21):34796-34810. PubMed ID: 28415793
    [Abstract] [Full Text] [Related]

  • 38. Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
    Werner TV, Kock S, Weber I, Kayser G, Werner M, Lassmann S.
    J Mol Diagn; 2022 Jul 23; 24(7):784-802. PubMed ID: 35787794
    [Abstract] [Full Text] [Related]

  • 39. Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.
    Volckmar AL, Christopoulos P, Kirchner M, Allgäuer M, Neumann O, Budczies J, Rempel E, Horak P, Glade J, Goldschmid H, Seker-Cin H, Brandt R, Kriegsmann M, Leichsenring J, Winter H, Faehling M, Fischer JR, Heußel CP, Herth F, Brummer T, Fröhling S, Schirmacher P, Thomas M, Endris V, Penzel R, Kazdal D, Bochtler T, Stenzinger A.
    Lung Cancer; 2021 Apr 23; 154():131-141. PubMed ID: 33667718
    [Abstract] [Full Text] [Related]

  • 40. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S, Satapathy A, Aggarwal A, Dewan A, Jain E, Katara R, Kumar V, Pal R, Pandey S, Naidu MM, Kini L, Pradhan D, Mohanty SK.
    Pathol Res Pract; 2021 Apr 23; 220():153394. PubMed ID: 33706124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.